Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma

Published:2022-08 Issue: Volume: Page:
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Choi Yonghyun,Son Wooic,Han Youngpin,Chae Jayoung,Yang Chul-Su,Choi Jonghoon

Funder

Ministry of Science, ICT and Future Planning

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference37 articles.

1. Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity;Chamoto;Proc Natl Acad Sci USA,2017

2. The microbiome, cancer, and cancer therapy;Helmink;Nat Med,2019

3. Controlled drug delivery vehicles for cancer treatment and their performance;Senapati;Signal Transduct Target Ther,2018

4. Current challenges in cancer treatment;Zugazagoitia;Clin Ther,2016

5. Tumor microenvironment and radioresistance;Suwa;Exp Mol Med,2021

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sonocatalytic oncolysis microbiota curb intrinsic microbiota lactate metabolism and blockade CD24-Siglec10 immune escape to revitalize immunological surveillance;Biomaterials;2024-12

2. The potential of biomimetic nanoparticles for macrophage repolarisation and phagocytosis in tumour immunotherapy;Chemical Engineering Journal;2024-10

3. Lectins in oncology and virology: Mechanisms of anticancer activity and SARS-CoV-2 inhibition;International Journal of Biological Macromolecules;2024-08

4. Zinc oxide nanoparticles with catalase-like nanozyme activity and near-infrared light response: A combination of effective photodynamic therapy, autophagy, ferroptosis, and antitumor immunity;Acta Pharmaceutica Sinica B;2024-07

5. Bridging the gap between testing and clinics exploring alternative pre-clinical models in melanoma research;Advanced Drug Delivery Reviews;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3